How long does the flu last: recovery times and factors affecting them

Influenza is not just a "cold with a fever." It is an acute viral respiratory disease caused by RNA viruses of the genus *Influenzavirus*, which can quickly mutate and evade the body's immune defenses. Unlike ARVI, influenza begins suddenly: within hours, the temperature rises to 39–40 °C, body aches occur, there is a severe headache, weakness, dry cough, and eye irritation. Many patients spend the first day in a state close to feverish stupor — a person cannot get out of bed, and even drinking water becomes difficult. That is why it is important to understand: influenza is not a reason to "wait it out at home," but a serious condition that requires attention, especially in children, the elderly, and people with chronic illnesses.

Classification of the disease according to ICD

According to the International Classification of Diseases 11th Revision (ICD-11), influenza falls under the section "Infectious and parasitic diseases" (block BA) and has the following codes:

• J09 — influenza caused by the influenza A virus, subtype H5N1 (avian influenza);
• J10 — influenza caused by other identified influenza viruses (for example, seasonal influenza A or B);
• J11 — influenza, virus not identified ("unspecified influenza").

Important: code J11 does not mean "mild form" — it is used when laboratory confirmation is absent, but the clinical picture is typical for influenza. In Russia, when issuing a sick leave certificate and for epidemiological surveillance, J10 is more often used if there is confirmation by PCR or ELISA. Also, in ICD-11, subcodes for complications are highlighted: for example, J10.1 — influenza with pneumonia, J10.2 — with bronchitis, J10.8 — with other complications (myocarditis, meningitis, myositis).

History of the disease and interesting historical facts

Influenza has been known to humanity since ancient times. The first reliable description of an epidemic that meets modern criteria for influenza dates back to 1580 — at that time, an outbreak swept through Asia, Africa, and Europe, claiming thousands of lives. However, the real "boom" of influenza occurred in the 20th century. The most devastating pandemic — the "Spanish flu" of 1918–1919 — claimed between 50 and 100 million lives worldwide. It affected not only the elderly, as is usually the case, but also young healthy people aged 20–40. Scientists still debate: the culprit is the H1N1 virus, which likely mutated from a swine or avian strain, and its particular aggressiveness was associated with a cytokine storm — an uncontrolled response of the immune system.
Another curious fact: the name "Spanish flu" became established not because the epidemic started in Spain — the country was neutral in World War I and did not impose censorship on news about the disease. While in Germany, France, Britain, and the USA, information was concealed to avoid undermining morale. Therefore, Spain was most often mentioned in international media — and the name stuck.
In 1957, the "Asian" form of influenza (H2N2) broke out worldwide, and in 1968 — the "Hong Kong" strain (H3N2). Both strains arose due to the recombination of human and avian viruses. By the way, it was in 1968 that the method of sequencing the viral genome was first applied — this became a starting point for modern virology.

Epidemiology (statistics of disease occurrence)

Seasonal influenza is one of the most common infectious diseases in the world. According to WHO, every year, influenza affects between 51 million to 151 million people worldwide. This amounts to 290–650 million cases per year. Of these, 3–5 million are severe cases, and 290–650 thousand are fatal outcomes. In Russia, according to Rospotrebnadzor, in the 2022/2023 season, about 12 million cases of ARVI were registered, of which approximately 15–20% were laboratory-confirmed influenza. The peak incidence occurs from December to February, although in certain years (for example, in 2020–2021), the epidemic peak shifted to spring due to disruptions in usual contact patterns during the COVID-19 pandemic.
Statistics by age groups:

• Children under 5 years old have the highest incidence (up to 20–30% in the season), but the mortality rate is low;
• People over 65 years old have low incidence (about 5–7%), but a high rate of hospitalizations and fatalities;
• Pregnant women have a hospitalization risk 3–5 times higher than that of non-pregnant women.

Interestingly, in recent years, there has been a "shift downward" in age: severe cases are increasingly being recorded in people aged 30–50 without chronic diseases. This is likely related to changes in circulating strains and a decrease in herd immunity after prolonged quarantines.

Genetic predisposition to this disease

Genetic predisposition to severe influenza is not a myth, but a scientifically confirmed fact. Studies show that variants of certain genes influence susceptibility to the virus and the strength of the immune response.
Key genes:

• IFITM3 (interferon-inducible transmembrane protein 3) - regulates the entry of the virus into the cell. In carriers of the rs12252-C mutation, the risk of hospitalization due to influenza increases by 6 times;
• HLA (human leukocyte antigen genes) - for example, HLA-B*27 and HLA-DQB1*06 are associated with a milder course, while HLA-A*02 is associated with increased sensitivity to the H1N1 virus;
• TLR3 and TLR7 - receptors that recognize viral RNA. Mutations here disrupt the initiation of the interferon response;
• MBL2 (mannose-binding lectin) — a protein of innate immunity. Deficiency increases the risk of secondary bacterial pneumonia.

Important: the presence of a "risk" mutation does not mean that a person will necessarily become seriously ill. It only increases the likelihood under otherwise equal conditions — for example, when exposed to a high viral load or in the absence of vaccination. Genetic testing for such markers is not yet part of standard practice but is actively being studied within the framework of personalized medicine.

Risk factors for the development of this disease

Risk factors can be divided into three groups: biological, behavioral, environmental.
Biological:

• Age: children under 2 years and people over 65 years;
• Chronic diseases: asthma, COPD, heart failure, diabetes, immunodeficiencies;
• Pregnancy (especially the II–III trimester);
• Obesity (BMI ≥ 40 — an independent risk factor for severe influenza).

Behavioral:

• Refusal of vaccination;
• Smoking (reduces the function of the ciliated epithelium of the respiratory tract);
• Chronic stress and lack of sleep — suppress interferon production;
• Vitamin D deficiency (correlates with the frequency of ARVI in the winter period).

Environmental:

• Dense collectives (schools, army, offices with air conditioning);
• Air pollution (PM2.5 damages the mucous membrane of the nasopharynx);
• Low humidity (<40%) — the virus remains viable in aerosol for a longer time.

It is particularly worth noting the professional risks: healthcare workers, teachers, transport and trade employees have a 2–3 times higher chance of getting infected during the epidemic season. At the same time, they often continue to work "on their feet," exacerbating the course of the disease and increasing the risk of transmission.

Diagnosis of this disease

The diagnosis of "influenza" is made based on a combination of clinical picture and laboratory confirmation. During the epidemic season, typical symptoms are sufficient for prescribing antiviral therapy without waiting for test results — as recommended by WHO and the Ministry of Health of the Russian Federation.
Main symptoms:

• Acute onset (within 1–2 hours);
• Temperature ≥ 38 °C;
• Myalgia (muscle aches), headache, weakness;
• Dry cough, sore throat, nasal congestion (often moderate);
• Absence of runny nose as a leading symptom (unlike ARVI).

Laboratory tests:

• Real-time PCR — "gold standard". Detects viral RNA in a nasopharyngeal swab. Sensitivity >95%, result in 2–4 hours;
• ELISA (enzyme-linked immunosorbent assay) — rapid antigen test (result in 15–30 minutes), but sensitivity is lower (60–70%);
• Viral culture — used only in reference laboratories for studying strains;
• Serology — determination of antibodies (IgM/IgG) in paired sera (acute and after 10–14 days). Rarely used, mainly for epidemiological investigations.

Radiological examinations:
Chest X-ray is prescribed when complications are suspected — primarily pneumonia. Typical signs: focal or diffuse opacity, more often in the lower lobes of the lungs. CT is not required in routine cases but may be useful in atypical presentations or in patients with severe immunodeficiency.
Differential diagnosis:
Influenza needs to be distinguished from:

• ARVI (adenoviruses, rhinoviruses) — onset is gradual, runny nose is more pronounced, temperature is lower;
• COVID-19 — symptoms overlap, but more often — loss of smell, diarrhea, shortness of breath in early stages;
• Bacterial pneumonia — temperature may not be very high, but cough with purulent sputum, leukocytosis;
• Mononucleosis (EBV) — in adolescents and young adults: lymphadenopathy, tonsillitis with exudate, hepatosplenomegaly.

Treatment

Influenza treatment is complex and depends on the timing of the visit, the patient's age, and the presence of risk factors. The main rule: start antiviral therapy within the first 48 hours of symptom onset. After that, effectiveness drops sharply.
General treatment:

• Bed rest — at least 5–7 days, even if the temperature has dropped. Physical activity can provoke myocarditis;
• Abundant alkaline drinking — mineral water, rosehip decoction, tea with honey (if there is no allergy). The goal is to compensate for fluid loss during fever and to thin mucus;
• Humidification of the air — optimal humidity 50–60%. Without this, the mucous membrane dries out, and the virus lingers longer in the respiratory tract;
• Nutrition — easily digestible, rich in protein and vitamins (chicken broth, stewed vegetables, porridge). Do not force to eat — appetite will return in 3–4 days.

Pharmacological treatment:
The basis consists of neuraminidase inhibitors:

• Oseltamivir (Tamiflu, Nomides) — orally, 75 mg twice a day for 5 days. Effective against A and B;
• Zanamivir (Relenza) — inhaled, twice a day for 5 days. Not suitable for bronchial asthma;
• Peramivir (Rapivab) — intravenously, single dose. For hospitalized patients.

Since 2020, **baloxavir marboxil** has been registered in the Russian Federation — an inhibitor of cap-dependent endonuclease. Acts faster: a single dose of 40 mg (20 mg for children) in the first 48 hours reduces viral load within 24 hours. Especially relevant for individuals at high risk of complications.
Symptomatic therapy:

• Antipyretics: paracetamol (max. 4 g/day) or ibuprofen (if there is no gastrointestinal ulcer). Aspirin is prohibited for children under 15 years (risk of Reye's syndrome);
• Cough suppressants — only for dry, painful cough (Codeine, Sinecod). Expectorants — when transitioning to a wet cough;
• Nasal decongestant drops — no more than 5 days (xylometazoline, naphazoline), otherwise — medication-induced rhinitis.

Surgical treatment for influenza is not used. However, in case of complications — for example, lung abscess or pleural empyema — drainage or thoracoscopic sanitation may be required.

List of medications used to treat this disease

Here is a summary table of medications approved for use in the Russian Federation as of 2026:

<threcommended dose (adults)

Note: Interferon-based drugs (Viferon, Genferon) and immunomodulators (Immunal, Anaferon) are not included in the WHO and Ministry of Health protocols as primary treatment. Their use is possible as an adjunct, but does not replace antiviral therapy.

Disease monitoring

Monitoring the course of influenza is not just "checking the temperature." It is a systematic assessment of the risk of complications.
Control stages:

• Day 1–2 — confirmation of the diagnosis, initiation of antiviral therapy;
• Day 3–4 — assessment of dynamics: decrease in temperature, reduction of weakness. If the temperature has not dropped or has returned — suspect bacterial superinfection;
• Day 5–7 — disappearance of fever, but persistence of cough and weakness — normal. If the cough worsens, purulent sputum appears, shortness of breath — urgently to the doctor;
• Day 10+ — recurrence of temperature or deterioration of condition — a sign of secondary pneumonia, myocarditis, or sepsis.

Forecast:
In healthy adults without risk factors, recovery occurs within 7–10 days. However, weakness and cough may persist for 2–3 weeks — this is not a complication, but a consequence of inflammation in the airways. In the elderly and those with chronic conditions, the duration extends to 14–21 days.
Complications:

• Bacterial pneumonias — the most common (Streptococcus pneumoniae, Staphylococcus aureus);
• Acute bronchitis and tracheitis — especially in smokers;
• Myocarditis and pericarditis — manifest as pain behind the sternum, arrhythmia;
• Neurological complications — encephalopathy, Guillain-Barré syndrome (very rare);
• Multiple organ failure syndrome — in severe cases, especially with delayed therapy.

Important: even after recovery, it is necessary to avoid physical exertion for 2–3 weeks. The heart and lungs are still "recovering," and overexertion can provoke complications.

Age-related features of the disease

Influenza in children, adults, and the elderly is almost different diseases.
Children under 3 years:
Often starts with vomiting, diarrhea, and cramps (due to high temperature). The temperature can reach 40.5 °C. The risk of dehydration is high — it is necessary to monitor urination (at least once every 3 hours). In infants, apnea (brief cessation of breathing) may occur. Antiviral medications are prescribed from 1 year (oseltamivir) or from 5 years (zanamivir).
Children aged 3–12 years:
Typical picture: high fever, body aches, refusal to eat. Earache (otitis) or sinusitis often accompanies. It is important not to give aspirin — risk of Reye's syndrome. Schoolchildren can "return to school" on the 5th day — but this is dangerous: the virus is still shedding, and the risk of relapse is high.
Adolescents and young adults (15–40 years):
Most often a mild course, but in the absence of vaccination, severe forms are possible. A special group is athletes: after the flu, training should be resumed gradually, starting with 30% load. A sharp return to training is a direct path to myocarditis.
People over 65 years old:
Often the temperature does not rise above 37.5–38 °C — an "atypical" form. However, weakness, confusion, and shortness of breath develop quickly. In 30% elderly patients, the flu is masked as an exacerbation of a chronic disease (for example, heart failure). The mortality rate in this group is up to 5–10% in severe forms.

Questions and Answers

Question 1: How many days does the flu last in an adult without complications?
Usually, fever lasts 3–5 days, general weakness — 7–10 days, cough may persist for up to 2–3 weeks. Important: if the temperature dropped on the 3rd day, and rose again to 38.5+ on the 5th day — this is not a "second wave of the flu," but most likely bacterial pneumonia. Urgent consultation with a doctor is needed, and possibly an X-ray.
Question 2: Can the flu be treated without antiviral drugs?
Yes, if you have no risk factors (age, chronic diseases, pregnancy) and you sought help later than 48 hours. In this case, the key is symptomatic therapy and rest. But remember: without antivirals, the risk of complications is higher by 30–40%. Especially if you work in the service sector or live with elderly people.
Question 3: Why does the cough persist for a long time after the flu?
This is not a "residual effect," but a sign of recovery of the respiratory mucosa. The virus damages the ciliated epithelium, and the body "cleans" the airways through coughing. If the cough is dry and does not worsen — this is normal. If sputum with pus, blood appears, or the cough does not decrease after 14 days — a consultation with a pulmonologist is needed.
Question 4: How many days after the flu can one go outside?
At least 24 hours after the normalization of temperature without antipyretics. But it's better — after 5–7 days from the onset of the illness. Even if you feel well, the virus is still released into the environment, and you can infect others. This is especially true for people with chronic diseases — they may experience the flu more severely than you.
Question 5: Does vaccination affect recovery times?
Yes, but not in the way people think. Vaccination does not "cure" the flu, but makes its course milder: lower temperature (37.5–38.5 °C instead of 39+), fewer complications, faster recovery. Vaccinated individuals have a lower viral load, so the immune system copes more effectively. Even if you get sick after vaccination — it’s not that "the vaccine didn’t work," but a strain not included in the vaccine (which happens due to mutations).

Typical mistakes made by patients

• "I’m no longer feverish — that means I’ve recovered."The temperature has dropped, but the virus is still in the lungs. Returning to work on the 4th day is a direct path to complications and infecting colleagues. The rule: at least 5 days of rest with the flu.
• Self-prescribing antibiotics.The flu is a virus; antibiotics are useless against it. They are prescribed only in case of confirmed bacterial superinfection (based on blood tests or X-rays). Self-treatment with antibiotics leads to dysbiosis and resistance.
• Continuing physical activity.Running, gym workouts, heavy housework — all of this is dangerous on the 7th–10th day after the flu. The heart is still recovering, and the load can provoke arrhythmia or myocarditis.
• Ignoring vaccination "because I got sick after it last time."Vaccination reduces severity, but does not guarantee 100% protection. Even if you get sick — it is not a vaccine error, but a feature of the virus. Each season the vaccine is updated for circulating strains.
• Treatment "on a friend's advice": hot foot baths, sauna, mustard.During fever, these methods increase the load on the heart and can provoke collapse. A hot bath is allowed only after normalizing temperature and in the absence of heart problems.

Conclusion

Influenza is not "just a cold," but a serious infectious disease that can lead to severe complications in just a few days. Recovery times depend not on the "strength of the body," but on three key factors: the timeliness of starting antiviral therapy, the presence of risk factors, and adherence to rest. In a healthy adult without chronic diseases, influenza lasts 7–10 days, but if recommendations are ignored, it can easily stretch to 2–3 weeks with complications.
The best prevention is annual vaccination in the fall (from September to November), hand hygiene, airing rooms, and humidifying the air. If you notice an acute onset with a temperature above 38 °C, aches, and weakness — do not wait, consult a doctor within the first 48 hours. In this window, antiviral medications work most effectively.
Remember: your task is not to "wait it out," but to help your body cope with the virus with minimal losses. Rest, hydration, proper medications, and monitoring — this is the formula for quick and safe recovery. And yes — if you are reading this while in bed with a fever, know: you are not alone. Millions experience influenza. The main thing is not to rush, not to ignore the signals of your body, and to trust proven methods, not folk advice. You will manage.